Leerink Partners Starts AnaptysBio (ANAB) at Outperform
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $58.47 +4.37%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst David Risinger initiates coverage on AnaptysBio (NASDAQ: ANAB) with a Outperform rating and a price target of $47.00.
For an analyst ratings summary and ratings history on AnaptysBio click here. For more ratings news on AnaptysBio click here.
Shares of AnaptysBio closed at $21.27 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Leerink Starts Freenome Inc. (FRNM) at Outperform
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
